IPM Insights

Drug discovery, development, and commercialization is like a puzzle. The end may be easy to visualize, but there are many pieces that need to be…

The product development timeline for a new pharmaceutical is fragile. If one link in the chain breaks, it delays everything else, including clinical trials, regulatory…

There’s an adage that says what gets measured gets improved. Regulatory submissions are no exception. And with the growing complexity of clinical trials and increasing…

The potential gains from digital pathology are endless. The ability to capture, curate, analyze, and rapidly share information about the effects of newly developed molecules…

Companies often begin achieving some business benefits of a merger or acquisition as soon as the two entities become one. And forward-looking organizations are eager…

Successful mergers and acquisitions integrations depend on strong leadership and a consistent message of a compelling shared vision and strategy. Presumably, a sound strategy drove…

“Day One” is a key milestone in a merger or acquisition. The first day of legal ownership, Day One requires thorough planning to gain and…

What do successful mergers and acquisitions (M&A) integrations have in common? Timely and thorough planning. Companies often either wait too long to begin planning or…

Most people would agree that it’s better to prevent a crisis than to have to deal with one. But the reality is, by their nature,…

This article was originally published on MasterControl’s GxP Lifeline blog as How to Avoid—but Prepare for—Compliance Crises. What happens when a medical technology company gets…